Entasis Therapeutics Holdings Inc. Gains 176.62%

Entasis Therapeutics Holdings Inc. (ETTX:NASDAQ) shot up at $5.56, a gain of 176.6%. The stock got featured on our News Catalysts scanner on Sat 14 Mar 20 at 02:18 AM in the 'EARNINGS' category. From Tue 03 Mar 20, the stock recorded 20.00% Up Days and 27.27% Green Days
About Entasis Therapeutics Holdings Inc. (ETTX:NASDAQ)
Entasis Therapeutics Holdings Inc is a clinical-stage biopharmaceutical company. The company is engaged in the discovery, development, and commercialization of novel antibacterial products to treat serious infections caused by multi-drug resistant Gram-negative bacteria. It has the discovery, development, and commercialization of novel antibacterial products to treat serious infections caused by multi-drug resistant Gram-negative bacteria. Its products candidate includes etx2514sul, zoliflodacin, etx0282cpdp, and nbp program.
Top 10 Gainers:
- Biomerica, Inc. (BMRA:NASDAQ), 340.17%
- Entasis Therapeutics Holdings Inc. (ETTX:NASDAQ), 176.62%
- Waitr Holdings Inc. (WTRH:NASDAQ), 159.21%
- Blue Apron Holdings, Inc. (APRN:NYSE), 148.09%
- Applied DNA Sciences, Inc. (APDN:NASDAQ), 122.36%
- ShiftPixy, Inc. (PIXY:NASDAQ), 89.73%
- BIO-key International, Inc. (BKYI:NASDAQ), 74.91%
- Tutor Perini Corporation (TPC:NYSE), 60.82%
- Centogene N.V. (CNTG:NASDAQ), 57.51%
- DropCar, Inc. (DCAR:NASDAQ), 52.67%